MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
MS patients switch meds – will it work as well?
Disease control OngoingThis study looks at 184 people with relapsing-remitting multiple sclerosis who switched from the drug MabThera to a similar drug called Rixathon. Researchers want to see if the switch changes nerve damage, brain lesions, relapses, or disability. They will use existing medical rec…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Sponsor: Uppsala University • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Cycle-Synced workouts may ease MS fatigue, small study hints
Symptom relief OngoingThis study looks at whether tailoring physical activity to the phases of the menstrual cycle can reduce fatigue and improve well-being in women with relapsing-remitting multiple sclerosis. Twenty women with MS and a matched group without MS will exercise and report their energy, …
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Universidad de Almeria • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC
-
Healthy habits program aims to ease fatigue in MS patients
Symptom relief OngoingThis study tests whether educational programs on exercise, Mediterranean diet, and mental strategies can improve quality of life and reduce fatigue in women with relapsing-remitting multiple sclerosis. About 60 participants will be assigned to either supervised in-person sessions…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Universidad de Almeria • Aim: Symptom relief
Last updated May 18, 2026 12:04 UTC